Nanopublication

ID

http://purl.org/np/RATTKYuXt9v3tJu08ObBIT6x6-QSsIM6LQmBG4n0QkbW4
Formats

Content

@prefix biolink: <https://w3id.org/biolink/vocab/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix this: <http://purl.org/np/RATTKYuXt9v3tJu08ObBIT6x6-QSsIM6LQmBG4n0QkbW4> .
@prefix sub: <http://purl.org/np/RATTKYuXt9v3tJu08ObBIT6x6-QSsIM6LQmBG4n0QkbW4#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix orcid: <https://orcid.org/> .
@prefix nkg: <https://w3id.org/um/neurodkg/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: a np:Nanopublication;
    np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo .
}

sub:assertion {
  sub:association a rdf:Statement;
    rdf:object <https://identifiers.org/MONDO:0005180>;
    rdf:predicate biolink:treats;
    rdf:subject <https://identifiers.org/CHEBI:63630>;
    rdfs:label "Tolcapone tablets, USP is indicated as an adjunct to levodopa and carbidopa for the treatment of the signs and symptoms of idiopathic Parkinson's disease";
    biolink:association_type biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation;
    biolink:provided_by "NeuroDKG";
    biolink:publications <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d94891be-2fef-4e39-8e35-ab7afe93e78e>;
    biolink:relation nkg:SymptomaticReliefIndication .
  
  <https://identifiers.org/CHEBI:63630> biolink:category biolink:Drug .
  
  <https://identifiers.org/MONDO:0005180> biolink:category biolink:Disease .
}

sub:provenance {
  sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB";
    npx:hasSignature "duyX2Ucsi5cPpckahHxqNzremtm3hCOaZQZ6g+ZXxeB4vLi2Z+BAlaFII9R7otf+y8xfZTgu77cQFeN+zI3MXmDxJ1M8SwusJ2jjw9p41Y1cY6W8pcoPzJbDeOvnMSQOxiDBSBVZ0aCViFA1vfhRFz+7vo/G5Eoo2OdA0I6UEP8=";
    npx:hasSignatureTarget this: .
  
  this: dcterms:created "2021-03-28T18:56:15.709+02:00"^^xsd:dateTime;
    dcterms:creator orcid:0000-0002-1468-3557;
    nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM>;
    nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM>;
    nt:wasCreatedFromTemplate <http://purl.org/np/RA59AEpaWRaR9sjdA0-n4zaQWdiZ6--iGafMrjrDAOheI> .
}